Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by bilosellhion Jul 12, 2004 2:46pm

350 Views

Post# 7700314

RE: Sub $5-ONCY

i think the real surge in volume coincidentally happened when oncy breached $5 US on nasdaq. looks like the longs will try to close it at or above $5 US today, but the question is how long will they be able to keep it there in the coming days & weeks without news from onc? i suspect those doing the selling have a pretty good idea if and when good news can be expected and it doesn't look to be anytime soon...there may be more buying opportunities below $5US in the coming days.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading